Related Experiment Video
Updated: Jun 10, 2026

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level
Published on: January 19, 2024
How Would You Manage This Patient With Iron Deficiency Anemia? Grand Rounds Discussion From Beth Israel Deaconess
Joséphine A Cool1, Kylee L Martens2, Jason A Freed1
1Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts (J.A.C., J.A.F., Z.K.).
Iron deficiency anemia (IDA) is a common global health issue. This discussion highlights diagnostic challenges and treatment uncertainties for IDA, especially in women, referencing new guidelines.
Area of Science:
- Hematology
- Internal Medicine
- Clinical Guidelines
Background:
- Iron deficiency anemia (IDA) is the most prevalent cause of anemia globally, leading to significant disability.
- Women of reproductive age are particularly susceptible due to menstrual blood loss and gynecologic conditions.
- Iron deficiency (ID) can exist without anemia, and standard hemoglobin thresholds may miss diagnoses in menstruating women due to sex-specific reference ranges.
Purpose of the Study:
- To discuss areas of uncertainty in the diagnosis, evaluation, and treatment of IDA.
- To provide insights based on the 2025 Iron Consortium Guideline.
- To illustrate challenges with a case study of a young woman with ID.
Main Methods:
- Review of current guidelines and literature on IDA diagnosis and management.
- Discussion of diagnostic work-up including gynecologic evaluation, endoscopy, and specific disease testing.
- Consideration of oral versus intravenous iron therapy options.
Main Results:
- Guidelines for IDA diagnosis and management vary, influenced by population, clinical context, and evidence quality.
- Accurate diagnosis requires assessing both iron deficiency and anemia, considering potential limitations of hemoglobin thresholds.
- Identifying the underlying cause of ID/IDA is crucial for effective treatment.
Conclusions:
- Addressing diagnostic ambiguities and treatment variations in IDA is essential for improved patient outcomes.
- The 2025 Iron Consortium Guideline aims to clarify management strategies.
- Individualized patient assessment is key, particularly for women of reproductive age.
Related Concept Videos
Peritoneal Dialysis III: Nursing Management
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Rheumatic Heart Disease IV: Nursing Management
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Heart Failure V: Medical Management
Cardiomyopathy VI: Nursing Management

